Currently, acetylcholinesterase inhibitors (AChEI) are the standard treatment for cognitive symptoms in Alzheimer's disease (AD) [7], and are also used in other forms of dementia, including vascular dementia (VaD) and Lewy body disease (LBD) [8, 9]. The gene discussed is ACHE; the disease is Alzheimer disease.